Arcadia Biosciences reported earnings of $ 0.29 per RKDA share on Nov 12, 2026, falling short of analysts' expectations by
| Report Date | Nov 12, 2026 |
|---|---|
| Forecasted EPS | -$ 0.46 |
| Earnings Per Share (Surprise) | $ 0.29 (+$ 0.75) |
| Last Year's EPS | $ 0.39 |
| EPS YoY Change |
Out of the last 54 earnings reporting periods, Arcadia Biosciences beat analysts’ expectations 19 times and fell short of expectations 26 time(s). Arcadia Biosciences reported earnings per share of $ 0.29 in the last report surpassing an estimated EPS of -$ 0.46 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 12, 2026 | -$ 0.46 | $ 0.29 | $ 0.62 | |
| Aug 13, 2026 | -$ 0.56 | -$ 2.09 | $ 0.02 | |
| May 14, 2026 | -$ 0.80 | -$ 2.11 | $ 1.90 | |
| Mar 26, 2026 | -$ 0.66 | -$ 0.98 | -$ 2.48 | |
| Nov 7, 2025 | -$ 0.54 | $ 0.62 | -$ 1.18 | |
| Aug 14, 2025 | -$ 0.79 | $ 0.02 | $ 0.78 | |
| May 8, 2025 | -$ 0.98 | $ 1.90 | -$ 1.78 | |
| Mar 20, 2025 | -$ 0.89 | -$ 2.48 | -$ 2.48 | |
| Nov 12, 2024 | -$ 0.77 | -$ 1.18 | -$ 1.83 | |
| Aug 13, 2024 | $ 1.55 | $ 0.78 | -$ 2.64 | |
| May 9, 2024 | -$ 2.52 | -$ 1.78 | -$ 10.86 | |
| Mar 28, 2024 | -$ 2.68 | -$ 2.48 | -$ 6.31 | |
| Nov 9, 2023 | -$ 2.67 | -$ 1.83 | -$ 4.80 | |
| Aug 10, 2023 | -$ 4.92 | -$ 2.64 | -$ 6.80 | |
| May 11, 2023 | -$ 6.35 | -$ 10.86 | -$ 8.40 | |
| Mar 30, 2023 | $ 6.80 | -$ 6.31 | -$ 16.80 | |
| Nov 10, 2022 | -$ 7.60 | -$ 4.80 | -$ 14.80 | |
| Aug 11, 2022 | -$ 12.40 | -$ 6.80 | -$ 10.40 | |
| May 12, 2022 | -$ 12.40 | -$ 8.40 | -$ 8.40 | |
| Mar 30, 2022 | -$ 11.20 | -$ 16.80 | $ 0.40 |
Arcadia Biosciences’s stock was trading at $ 0.2378 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, RKDA’s price decreased to $ 0.218 on Nov 13, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 12, 2026 | $ 0.29 | $ 0.2378 | $ 0.218 | |
| Aug 13, 2026 | -$ 2.09 | $ 0.70 | $ 0.6246 | |
| May 14, 2026 | -$ 2.11 | $ 1.06 | $ 0.9556 | |
| Mar 26, 2026 | -$ 0.98 | $ 1.70 | $ 1.47 | |
| Nov 7, 2025 | $ 0.62 | $ 3.90 | $ 3.61 | |
| Aug 14, 2025 | $ 0.02 | $ 4.63 | $ 4.65 | |
| May 8, 2025 | $ 1.90 | $ 4.30 | $ 3.88 | |
| Mar 20, 2025 | -$ 2.48 | $ 3.44 | $ 3.15 | |
| Nov 12, 2024 | -$ 1.18 | $ 4.24 | $ 4.19 | |
| Aug 13, 2024 | $ 0.78 | $ 2.92 | $ 2.66 | |
| May 9, 2024 | -$ 1.78 | $ 1.98 | $ 2.06 | |
| Mar 28, 2024 | -$ 2.48 | $ 2.30 | $ 2.05 | |
| Nov 9, 2023 | -$ 1.83 | $ 3.35 | $ 3.14 | |
| Aug 10, 2023 | -$ 2.64 | $ 4.40 | $ 4.30 | |
| May 11, 2023 | -$ 10.86 | $ 6.03 | $ 5.15 | |
| Mar 30, 2023 | -$ 6.31 | $ 7.87 | $ 7.47 | |
| Nov 10, 2022 | -$ 4.80 | $ 12.40 | $ 12.24 | |
| Aug 11, 2022 | -$ 6.80 | $ 36.80 | $ 42.80 | |
| May 12, 2022 | -$ 8.40 | $ 33.32 | $ 40.40 | |
| Mar 30, 2022 | -$ 16.80 | $ 77.20 | $ 56.00 |
Arcadia Biosciences released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Arcadia Biosciences beat analysts’ expectations during the last earnings period by
